The impact of betaplus program on patient treatment satisfaction with interferon beta-1b in multiple sclerosis: Multicentric cross-sectional survey in the western Balkan countries

详细信息    查看全文

• 作者：Jelena Drulovic^a ; ^{jelena60@eunet.rs} ; Mirjana Cukic^b ; Sanja Grgic^c ; Evica Dincic^d ; Ranko Raicevic^d ; Congor Nadj^e ; Gordana Toncev^f ; Slobodan Vojinovic^g ; Sarlota Mesaros^a ; Darija Kisic Tepavcevic^h ; Irena Dujmovic^a ; Daliborka Tadic^c ; Svetlana Miletic-Drakulic^f ; Jelena Dackovic^a ; Smiljana Kostic^d ; Jevto Erakovic^b ; Lorand Sakalas^e ; Dejan Savic^g ; Vesna Suknjaja^e ; Vanja Martinovic^a ; Gorica Maric^h ; Tatjana Pekmezovic^h
• 关键词：Multiple sclerosis ; Interferon beta-1b ; Treatment satisfaction ; Adherence
• 刊名：Multiple Sclerosis and Related Disorders
• 出版年：2017
• 出版时间：January 2017
• 年：2017
• 卷：11
• 期：Complete
• 页码：56-61
• 全文大小：391 K
• 卷排序：11

文摘

Most interferon beta-1b patients are satisfied with treatment. Adherence rates and treatment satisfaction with interferon beta-1b is high. The programs of patient support improve treatment satisfaction in MS.